4.7 Article

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

How should we use convalescent plasma therapies for the management of COVID-19?

Erica M. Wood et al.

Summary: Convalescent plasma from blood donors with antibodies to SARS-CoV-2 may benefit COVID-19 patients by providing immediate passive immunity via transfusion or by being used to manufacture hyperimmune immunoglobulin preparations. Optimal characteristics, transfusion volume, and administration timing remain to be determined, requiring international collaborative efforts to establish clinical efficacy. Preliminary safety data for COVID-19 CP is encouraging, with ongoing large, high-quality randomized trials starting to report preliminary results.
Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Article Immunology

Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection

Flaminia Tomassetti et al.

Summary: The study found that hospitalized COVID-19 patients had higher levels of S-RBD and NT antibodies in their serum, while non-hospitalized patients had lower antibody levels, indicating a strong correlation between NT antibody levels and disease severity as well as S-RBD antibody levels.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Virology

Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan

Kazuo Imai et al.

Summary: The study analyzed antibody response patterns of COVID-19 patients in Japan according to disease severity. Results showed that patients with severe and critical cases had stronger antibody responses 11 days after symptom onset, while mild cases had lower seroconversion rates of antibodies against N and S1.

JOURNAL OF MEDICAL VIROLOGY (2021)

Editorial Material Microbiology

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Aiping Wu et al.

CELL HOST & MICROBE (2020)

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Immunology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Li Guo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Article Medicine, General & Internal

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19

Muthiah Vaduganathan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Article Multidisciplinary Sciences

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Corine H. GeurtsvanKessel et al.

NATURE COMMUNICATIONS (2020)

Article Medicine, Research & Experimental

Kinetics of viral load and antibody response in relation to COVID-19 severity

Yanqun Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Immunology

High neutralizing antibody titer in intensive care unit patients with COVID-19

Li Liu et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Virology

Serological assays for emerging coronaviruses: Challenges and pitfalls

Benjamin Meyer et al.

VIRUS RESEARCH (2014)